Group One Trading, L.P. Haleon PLC Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$8.02 - $8.67 $8,613 - $9,311	1,074 Added 128.93%	1,907 $16,000
Q4 2023 Feb 14, 2024	SELL	$7.78 - $8.62 $10,425 - $11,550	-1,340 Reduced 61.67%	833 $6,000
Q3 2023 Nov 09, 2023	SELL	$7.85 - $8.94 $53,380 - $60,792	-6,800 Reduced 75.78%	2,173 $18,000
Q2 2023 Aug 09, 2023	BUY	$8.04 - $9.0 $57,445 - $64,305	7,145 Added 390.86%	8,973 $75,000
Q1 2023 May 12, 2023	SELL	$7.57 - $8.37 $818,975 - $905,525	-108,187 Reduced 98.34%	1,828 $14,000
Q4 2022 Feb 09, 2023	SELL	$5.96 - $8.06 $451,392 - $610,440	-75,737 Reduced 40.77%	110,015 $880,000
Q3 2022 Nov 09, 2022	BUY	$5.63 - $7.5 $1.05 Million - $1.39 Million	185,752 New	185,752 $1.13 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.